{"id":"tretinoin-0-05","safety":{"commonSideEffects":[{"rate":"40-60","effect":"Erythema and irritation"},{"rate":"30-50","effect":"Peeling and dryness"},{"rate":"null","effect":"Photosensitivity"},{"rate":"20-40","effect":"Burning or stinging"}]},"_chembl":{"chemblId":"CHEMBL2218871","moleculeType":"Small molecule","molecularWeight":"713.14"},"_dailymed":{"setId":"a97a7bca-eada-141f-e053-2a95a90a1fe2","title":"011220 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% GEL [SINCERUS FLORIDA, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tretinoin activates nuclear retinoic acid receptors (RAR-α, RAR-β, RAR-γ), which modulate transcription of genes involved in cell proliferation and differentiation. In the skin, it increases cell turnover, normalizes keratinization, reduces sebaceous gland activity, and has anti-inflammatory effects. These actions make it effective for treating acne and photoaged skin.","oneSentence":"Tretinoin is a retinoid that binds to retinoic acid receptors to regulate gene expression, promoting cell differentiation and reducing sebum production and comedone formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:11:15.075Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"},{"name":"Photoaged skin and wrinkles"},{"name":"Keratosis pilaris"}]},"trialDetails":[{"nctId":"NCT06787222","phase":"PHASE2, PHASE3","title":"Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hasanuddin University","startDate":"2024-11-03","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT07012811","phase":"PHASE4","title":"Treatment of Plane Warts With Topical and Oral Retinoids","status":"COMPLETED","sponsor":"Tishreen University","startDate":"2024-02-12","conditions":"Plane Warts","enrollment":39},{"nctId":"NCT06780644","phase":"NA","title":"Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2025-02-17","conditions":"Melasma","enrollment":56},{"nctId":"NCT06013540","phase":"PHASE2","title":"Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.","status":"UNKNOWN","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2022-08-01","conditions":"Melasma","enrollment":122},{"nctId":"NCT06008327","phase":"NA","title":"Comparison Of Outcome Of Treatment OF Topical 15%TCA VS Topical 0.05% Tretinoin In Treatment Of Acanthosis Nigricans","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2022-08-01","conditions":"Acanthosis Nigricans","enrollment":80},{"nctId":"NCT05508191","phase":"NA","title":"Microneedle Versus Fractional CO₂ Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women","status":"COMPLETED","sponsor":"Shannaz Nadia Yusharyahya","startDate":"2022-08-17","conditions":"Skin Aging, Transepidermal Water Loss","enrollment":30},{"nctId":"NCT00669071","phase":"PHASE4","title":"Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma","status":"TERMINATED","sponsor":"Galderma R&D","startDate":"2008-01","conditions":"Melasma","enrollment":56},{"nctId":"NCT00647556","phase":"PHASE3","title":"Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-04","conditions":"Photoaging","enrollment":30},{"nctId":"NCT00472966","phase":"PHASE4","title":"Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-11","conditions":"Melasma","enrollment":20},{"nctId":"NCT05004909","phase":"NA","title":"Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream","status":"UNKNOWN","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2021-09-01","conditions":"Photoaging","enrollment":46},{"nctId":"NCT04835259","phase":"NA","title":"Efficacy of Topical Antioxidants in Tretment of Photoaging","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2021-04","conditions":"Photoaging","enrollment":90},{"nctId":"NCT04096742","phase":"PHASE4","title":"Altreno for Chest Rejuvenation","status":"UNKNOWN","sponsor":"Goldman, Butterwick, Fitzpatrick and Groff","startDate":"2019-08-06","conditions":"Photodamaged Skin, Photoaging","enrollment":40},{"nctId":"NCT01027793","phase":"PHASE4","title":"Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks","status":"COMPLETED","sponsor":"Hexsel Dermatology Clinic","startDate":"2009-03","conditions":"Stretch Marks, Striae, Treatment","enrollment":32},{"nctId":"NCT03933774","phase":"NA","title":"PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation","status":"COMPLETED","sponsor":"The Catholic University of Korea","startDate":"2019-04-29","conditions":"Vitiligo","enrollment":25},{"nctId":"NCT04118296","phase":"PHASE1, PHASE2","title":"Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream","status":"COMPLETED","sponsor":"Sukma Skin Treatment","startDate":"2019-10-08","conditions":"Acne Vulgaris","enrollment":150},{"nctId":"NCT04417348","phase":"NA","title":"Opsin Receptors in Melasma","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2019-01-31","conditions":"Melasma","enrollment":15},{"nctId":"NCT02249767","phase":"PHASE3","title":"Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel","status":"COMPLETED","sponsor":"Spear Pharmaceuticals","startDate":"2013-11","conditions":"Acne","enrollment":574},{"nctId":"NCT02932306","phase":"PHASE3","title":"Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2015-11-03","conditions":"Acne","enrollment":820},{"nctId":"NCT04206631","phase":"PHASE1","title":"Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2015-04-01","conditions":"Acne Vulgaris","enrollment":140},{"nctId":"NCT02965456","phase":"PHASE3","title":"Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2015-11-04","conditions":"Acne","enrollment":820},{"nctId":"NCT03433378","phase":"EARLY_PHASE1","title":"To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2017-08-04","conditions":"Acne Vulgaris","enrollment":700},{"nctId":"NCT03392623","phase":"EARLY_PHASE1","title":"DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2015-01-01","conditions":"Melasma","enrollment":28},{"nctId":"NCT01406080","phase":"PHASE3","title":"A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging","status":"COMPLETED","sponsor":"Galderma Brasil Ltda.","startDate":"2013-01","conditions":"Photoaging, Photodamage","enrollment":128},{"nctId":"NCT01149876","phase":"PHASE4","title":"Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-06","conditions":"Hyperpigmentation","enrollment":80},{"nctId":"NCT01125930","phase":"PHASE3","title":"Atralin Gel for the Treatment of Rosacea","status":"TERMINATED","sponsor":"Lisa E. Maier","startDate":"2010-05","conditions":"Rosacea","enrollment":68},{"nctId":"NCT01448733","phase":"PHASE4","title":"Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00842907","phase":"PHASE2","title":"Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2009-05","conditions":"Photodamage, Photoaging","enrollment":20},{"nctId":"NCT01085279","phase":"PHASE2","title":"Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)","status":"COMPLETED","sponsor":"Netherlands Institute for Pigment Disorders","startDate":"2009-03","conditions":"Pigmentation Disorder","enrollment":29},{"nctId":"NCT01083498","phase":"PHASE2","title":"Fractional Laser as Treatment Option for Various Pigment Disorders","status":"COMPLETED","sponsor":"Netherlands Institute for Pigment Disorders","startDate":"2009-03","conditions":"Pigmentation Disorder","enrollment":11},{"nctId":"NCT00975312","phase":"PHASE2","title":"Solar Lentigines Treatment With the Triple Combination Cream","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2008-08","conditions":"Lentigo","enrollment":22},{"nctId":"NCT00621218","phase":"PHASE2","title":"A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-02","conditions":"Rosacea","enrollment":36},{"nctId":"NCT00603772","phase":"PHASE1","title":"Clinical Evaluation of the Photoallergy Potential of Atralin Gel","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-01","conditions":"Healthy","enrollment":40},{"nctId":"NCT00604032","phase":"PHASE1","title":"Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-01","conditions":"Healthy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":113,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Retacnyl"],"phase":"marketed","status":"active","brandName":"Tretinoin 0.05%","genericName":"Tretinoin 0.05%","companyName":"Pontificia Universidad Catolica de Chile","companyId":"pontificia-universidad-catolica-de-chile","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tretinoin is a retinoid that binds to retinoic acid receptors to regulate gene expression, promoting cell differentiation and reducing sebum production and comedone formation. Used for Acne vulgaris, Photoaged skin and wrinkles, Keratosis pilaris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}